A single- and multiple-dose human pharmacokinetic study of cefretet for injection is proposed in healthy subjects. To evaluate the tolerability and safety of single and multiple intravenous infusions of cefretet for injection in healthy subjects, to calculate the main pharmacokinetic parameters, and to evaluate the test after single and multiple intravenous infusions of cefretet for injection The pharmacokinetic characteristics of the patients were examined; the excretion of the drugs in the urine was also investigated.
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.